TY - JOUR
T1 - Clinical spectrum of endemic leptospirosis in relation to cytokine response
AU - Dahanayaka, Niroshana J.
AU - Agampodi, Suneth B.
AU - Seneviratna, Indika
AU - Warnasekara, Janith
AU - Rajapakse, Rukman
AU - Ranathunga, Kosala
AU - Matthias, Michael
AU - Vinetz, Joseph M.
N1 - Publisher Copyright:
© 2021 Dahanayaka et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
PY - 2021/12
Y1 - 2021/12
N2 - Objectives To describe the clinical spectrum and the cytokine response of leptospirosis patients in an endemic setting of Sri Lanka. Methods Patients presenting to the university teaching hospital, Anuradhapura, Sri Lanka with a leptospirosis- compatible illness were recruited over a period of 12 months starting from June 2012. Daily clinical and biochemical parameters of the patients were prospectively assessed with a follow-up of 14 days after discharge. A magnetic bead-based multiplex cytokine kit was used to detect 17 cytokines. Results Of the 142 clinically suspected leptospirosis patients recruited, 47 were confirmed and, 29 cases were labeled as "probable."Thrombocytopenia and leukocytosis were observed at least once during the hospital stay among 76(54%) and 39(28%) patients, respectively. Acute kidney injury was observed in 31 patients (22%) and it was significantly higher among confirmed and probable cases. Hu TNF-α and IL-1β were detected only in patients without complications. Hu MIP-1b levels were significantly higher among patients with complications. During the convalescence period, all tested serum cytokine levels were lower compared to the acute sample, except for IL-8. The cytokine response during the acute phase clustered in four different groups. High serum creatinine was associated GM-CSF, high IL-5 and IL-6 level were correlates with lung involvement and saturation drop. The patients with high billirubin (direct)>7 mmol/l had high IL-13 levels. Conclusions Results of this study confirms that the knowledge on cytokine response in leptospirosis could be more complex than other similar tropical disease, and biosignatures that provide diagnostic and prognostic information for human leptospirosis remain to be discovered.
AB - Objectives To describe the clinical spectrum and the cytokine response of leptospirosis patients in an endemic setting of Sri Lanka. Methods Patients presenting to the university teaching hospital, Anuradhapura, Sri Lanka with a leptospirosis- compatible illness were recruited over a period of 12 months starting from June 2012. Daily clinical and biochemical parameters of the patients were prospectively assessed with a follow-up of 14 days after discharge. A magnetic bead-based multiplex cytokine kit was used to detect 17 cytokines. Results Of the 142 clinically suspected leptospirosis patients recruited, 47 were confirmed and, 29 cases were labeled as "probable."Thrombocytopenia and leukocytosis were observed at least once during the hospital stay among 76(54%) and 39(28%) patients, respectively. Acute kidney injury was observed in 31 patients (22%) and it was significantly higher among confirmed and probable cases. Hu TNF-α and IL-1β were detected only in patients without complications. Hu MIP-1b levels were significantly higher among patients with complications. During the convalescence period, all tested serum cytokine levels were lower compared to the acute sample, except for IL-8. The cytokine response during the acute phase clustered in four different groups. High serum creatinine was associated GM-CSF, high IL-5 and IL-6 level were correlates with lung involvement and saturation drop. The patients with high billirubin (direct)>7 mmol/l had high IL-13 levels. Conclusions Results of this study confirms that the knowledge on cytokine response in leptospirosis could be more complex than other similar tropical disease, and biosignatures that provide diagnostic and prognostic information for human leptospirosis remain to be discovered.
UR - https://www.scopus.com/pages/publications/85120911355
U2 - 10.1371/journal.pone.0261025
DO - 10.1371/journal.pone.0261025
M3 - Artículo
C2 - 34879100
AN - SCOPUS:85120911355
SN - 1932-6203
VL - 16
JO - PLoS ONE
JF - PLoS ONE
IS - 12 December
M1 - e0261025
ER -